Gayle DiLalla
-
- Breast Cancer Treatment Studies 15
-
- Cancer Treatment and Pharmacology 6
- Cancer Risks and Factors 4
- Global Cancer Incidence and Screening 3
- HER2/EGFR in Cancer Research 2
-
- Breast Lesions and Carcinomas 3
-
- Advanced Breast Cancer Therapies 6
-
- Hospital Admissions and Outcomes 2
- Co-authors
- Jennifer K. PlichtaSamantha M. ThomasOluwadamilola M. FayanjuSarah SammonsE. Shelley HwangCarolyn S. MenendezRachel A. GreenupTerry Hyslop
- Journals
- Journal of Clinical Oncology (1 paper)Cancer (3 papers)The American Journal of Surgery (2 papers)
- Partner nations
- United StatesCanada
In The Last Decade
Gayle DiLalla
13 papers receiving 101 citations
Peers
Comparison fields: 5 of 32
- Cancer Research 54
- Oncology 64
- Pathology and Forensic Medicine 16
- Pulmonary and Respiratory Medicine 22
- Gender Studies 6
Countries citing papers authored by Gayle DiLalla
This map shows the geographic impact of Gayle DiLalla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gayle DiLalla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gayle DiLalla more than expected).
Fields of papers citing papers by Gayle DiLalla
This network shows the impact of papers produced by Gayle DiLalla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gayle DiLalla. The network helps show where Gayle DiLalla may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gayle DiLalla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 0 | |
| 10 | 2022 | 4 | |
| 11 | 2022 | 12 | |
| 12 | 2021 | 7 | |
| 13 | 2021 | 24 | |
| 14 | 2021 | 10 | |
| 15 | 2021 | 22 | |
| 16 | 2021 | 4 | |
| 17 | 2021 | 1 | |
| 18 | 2021 | 1 | |
| 19 | 2020 | 11 |
About Gayle DiLalla
Gayle DiLalla is a scholar working on Cancer Research, Oncology and Gender Studies, having authored 19 papers that have together received 101 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (15 papers), Advanced Breast Cancer Therapies (6 papers), Cancer Treatment and Pharmacology (6 papers), Cancer Risks and Factors (4 papers), Global Cancer Incidence and Screening (3 papers), Breast Lesions and Carcinomas (3 papers), Hospital Admissions and Outcomes (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Cancer Research (54 citations), Oncology (64 citations) and Pathology and Forensic Medicine (16 citations). Gayle DiLalla has collaborated with scholars based in United States and Canada. Frequent co-authors include Jennifer K. Plichta, Samantha M. Thomas, Oluwadamilola M. Fayanju, Sarah Sammons, E. Shelley Hwang, Carolyn S. Menendez, Rachel A. Greenup, Terry Hyslop, E. Shelley Hwang and Laura H. Rosenberger. Their work appears in journals such as Journal of Clinical Oncology, Cancer and The American Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.